English
Pусский
Français
Deutsch
العربية
Português
Español
简体中文

News
Home / News / Company News
  • Onsite Training for HbA1c Analyzer GSH-60 in EgyptWe are thrilled to welcome a talented group of engineers to our GSH-60 HPLC HbA1c Analyzer training workshop in Egypt recently. This workshop is an exciting opportunity for all participants to delve deeply into both the theoretical and practical aspe
  • HbA1c Analyzer GSH-60 in KazakhstanGoldsite Diagnostics Inc., a leading manufacturer of medical IVDs (In Vitro Diagnostics), is pleased to announce that it has received the official registration certificate for its Automatic HbA1c Analyzer GSH-60 from the Ministry of Health of the Republic of Kazakh
  • Goldsite on TrendOn February 18th, Goldsite Diagnostics Inc., was invited to attend the 2024 Guangdong High-quality Development Conferences as the key representative from #enterprises, along with leading #hightech companies, to name a few, #BYD, #Tencent, #Mindray, and #DJI.About Guangdong High-qual
  • Düsseldorf, Germany- Today marks the grand opening of the 2023 MEDICA exhibition in Düsseldorf, Germany, drawing the global medical industry's attention. After months of meticulous preparation, the Goldsite team debuts with several inno
  • (Bangkok, Thailand, 18 August, 2023) The Medlab Asia 2023 has drawn its curtains, leaving behind a trail of innovation, collaboration, and impactful connections. As we pause to reflect on this event, we are thrilled to share our journey and the significant impact it has made on our presence in the
  • As we close this chapter, we want to express our gratitude towards the organizers of the 2023 AACC as well as to all those who visited our booth, engaged in insightful discussions, and showed interest in our products. We can't wait to see what the next year brings, and we look forward to connecting
  • Expanding to the new headquarter building, the new location will provide the necessary infrastructure for Goldsite Diagnostics Inc. to continue to build on our current momentum and sales in the China and International markets.
  • Dear valued client,We would like to thank you for your support and trust throughout the past year. We look forward to continuing our partnership and achieving great success together.We would like to inform you that our office will be closed for the Chinese New Year holiday from January 20th to Janua
  • Glad to share with you the news that all Goldsite's products are registered in the United Kingdom Medicines&Healthcare products Regulatory Agency (MHRA) now.#goldsite #mhra #unitedkingdom #uk #healthcare #ivd #ivdr #clinical #lab #laboratories #clinics #hospital #health
  • Omicron subvariants BA.4 and BA.5 now are responsible for the surge of cases globally. New studies suggest that BA.4 and BA.5 are so far the most transmissible variants. World Health Organization experts has recognized BA.4 and BA.5 continue to drive waves of cases, hospitalisation
Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents.

Get in touch

    (+86)-755-26890807

        (+86)-755-26897973
   export@goldsite.com.cn

 

Copyright © 1999- 2023 Goldsite Diagnostics Inc., All rights reserved.   Sitemap